Long-term alcoholic patients have a fivefold higher risk of post-operative bleeding complications compared with nonalcoholic individuals. Serotonin increases and cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) decrease platelet aggregation. We examined the plateletrich plasma levels of these substances and agonist-induced platelet aggregation in long-term alcoholic patients before and after surgery. Thirty-three consecutive patients (13 long-term alcoholics and 20 non-alcoholics) scheduled for tumour resections of the upper digestive tract were included in the study. The levels of cAMP were significantly decreased before and after surgery in long-term alcoholic patients, but there were no significant differences in cGMP and serotonin levels in alcoholic compared with non-alcoholic patients. In contrast to previous studies, no significantly altered aggregation responses in long-term alcoholics were found. A possible explanation is decreased inhibition through diminished cAMP levels; cGMP and serotonin do not seem to influence peri-operative haemostasis.
Introduction
Chronic alcohol misuse has been reported in 92% of patients with oral carcinoma and in 61% of patients with oesophageal carcinoma. 1 Patients with long-term alcohol abuse have a five-fold increased risk of postoperative bleeding complications compared with non-alcoholics. 2 Prolonged bleeding times and secondary platelet function disorders have been reported in these patients. 3 Alcohol itself can inhibit the aggregation of platelets in vivo and in vitro, which is induced by several agonists, such as thrombin, adenosine diphosphate (ADP) and collagen. 4 -6 In vivo circulating platelets are exposed to both adhesive and/or activating factors (e.g. ADP, fibrinogen, thrombin) and inhibitory factors such as endothelium-derived nitric oxide and prostacyclin (PGI2). 7, 8 The intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) influence platelet function significantly. 7 Intracellular cAMP blocks the formation of small and large aggregates, whereas intracellular cGMP H Schoenfeld, R Franke, C von Heymann et al. cAMP levels in long-term alcoholic patients appears to suppress the formation of large aggregates. 9 Decreased plasma cAMP levels have been found in chronic alcoholics. 10 Platelet incubation with alcohol resulted in inhibition of cGMP accumulation in platelets after stimulation by the nitric oxide donor sodium nitroprusside. 11 Serotonin (5-hydroxytryptamine, 5-HT) is stored in platelet-dense granules, and is released after platelet activation. In contrast to its powerful vasoconstrictor actions, serotonin on its own is a relatively weak platelet activator. 12, 13 Serotonin increases the effects of ADP, epinephrine and collagen on platelet aggregation and increases the release reaction through an increase in the free cytoplasmic intracellular Ca 2+ concentration. 14 Reduced platelet 15 and plasma 16 concentrations of serotonin were reported in patients with alcohol misuse. It was assumed that the lowering of serotonin may inhibit platelet function. 17 As the mechanisms for post-operative bleeding in chronic alcoholics have not been sufficiently investigated, this study focused on the influence of chronic alcohol misuse on levels of serotonin, cAMP and cGMP in platelet-rich plasma (PRP) and on platelet aggregation in patients undergoing tumour resection of the upper digestive tract. Additionally, all post-operative complications, such as blood transfusions and re-operations, pneumonia and alcohol withdrawal syndrome (AWS), were recorded.
Patients and methods

PATIENTS
Consecutive patients with a carcinoma of the upper digestive tract were admitted to this trial. Written informed consent was obtained from all patients and the study was approved by the local ethics committee according to the Declaration of Helsinki. Exclusion criteria were an age < 18 years, liver insufficiency (Child class B or C), having taken an antiplatelet drug in the previous 10 days, and regular intake of serotonin re-uptake inhibitors.
Chronic alcohol misuse was defined as a daily alcohol intake of at least 60 g and fulfilment of the Diagnostic and Statistical Manual for Mental Disorders (DSM)-IV criteria for alcohol abuse or dependence. 18 Controls were defined as patients with a daily alcohol intake of less than 60 g and without fulfilment of the DSM-IV criteria. The following diagnostic indicators for alcoholism were also recorded: the results of an alcoholism-related questionnaire (CAGE), 19 and laboratory markers such as γ-glutamyltransferase (GGT), mean corpuscular volume (MCV) and pre-surgery carbohydrate-deficient transferrin (CDT).
Duration of stay in the intensive care unit, laboratory markers and all post-operative complications were documented. Bleeding complications were defined as occasions when red blood cell (RBC) concentrate, fresh frozen plasma, platelet concentrates or haemostatic factors were administered or a bleeding-related re-operation was performed. Pneumonia was diagnosed by the US Centers for Disease Control criteria. 20 AWS was measured with the Revised Clinical Institute or Withdrawal Assessment for Alcohol Scale (CIWA-Ar score). 21 A CIWA-Ar of 20 or more was defined as AWS.
LABORATORY MARKERS
Carbohydrate-deficient transferrin was determined by microanion exchange chromatography and subsequent turbimetry according to the manufacturer's instructions (Cobas Mira ® , Roche Diagnostics, Grenzach-Wyhlen, Germany). The conventional laboratory variables MCV, GGT, haemoglobin and platelet count were obtained according to routine clinical practice.
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The ex vivo studies were performed before and 1 day after the operation. Blood samples were taken between 08:00 and 09:00. For platelet aggregation studies, PRP samples were obtained after centrifugation of citrated whole blood at 120 g for 10 min. The platelet counts of whole blood and the PRP were determined electronically (H1 Technicon, Tarrytown, New York, USA). Platelet samples were diluted with autologous platelet-poor plasma, which was obtained by additional centrifugation of an aliquot of PRP at 200 g for 10 min, to adjust the platelet number to 200 -250 × 10 9 /l. Aggregation responses to ADP (final concentration of 10 µmol/l), collagen (final concentration of 2 µg/ml), epinephrine (final concentration 20 µmol/l) and ristocetin (final concentration of 1.25 mg/ml) were recorded with an aggregometer (Platelet Aggregation Profiler ® -4; Mölab, Hilden, Germany). The aggregation response was defined as the maximum change in light transmittance after induction and was expressed as a percentage of plateletpoor plasma. Higher light transmittance indicated stronger platelet aggregation.
Blood samples for determining serotonin, cAMP and cGMP were collected in tubes containing EDTA (ethylene diamine tetraacetic acid) (Monovette ® ; Sarstedt Inc., Nürnbrecht, Germany). Blood samples were centrifuged at 10°C and 120 g for 10 min. Removed supernatant PRP was frozen immediately and stored at -70°C until the assays were performed.
The plasma serotonin levels were measured by an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer's instructions (Dianova-Immunotech, Hamburg, Germany). All determinations were expressed as ng/10 9 platelets.
The cAMP and cGMP levels in PRP were measured by radioimmunoassay using a commercial kit according to the manufacturer's instructions (Dianova-Immunotech). The assays used iodine 125 -cAMP and iodine 125 -cGMP, respectively as the tracer. All determinations were expressed as nmol/l.
STATISTICAL ANALYSIS
All data were expressed as median and 25th and 75th percentiles (interquartile range). Statistical analysis was performed with the Mann-Whitney U-test for comparisons between groups and the Wilcoxon test for comparisons within groups. Fisher's exact test was used to compare dichotomous variables. P-values < 0.05 were considered to be statistically significant.
Results
Thirteen (39%) of the 33 patients included in the study were diagnosed as being long-term alcoholics and 20 (61%) as being nonalcoholics. Long-term alcoholics and nonalcoholics differed significantly in results obtained by the CAGE questionnaire (P < 0.01) and in CDT levels (P < 0.01) ( Table 1) . Surgical procedures and anaesthesia were regarded as uncomplicated in all patients. No significant differences were found between long-term alcoholics and non-alcoholics in the length of stay in the intensive care unit, frequency of pneumonia, AWS and bleeding complications ( Table 2 ). The four chronic alcoholic patients who were transfused received a total of 10 units of RBCs, whereas the two non-alcoholic patients received 6 units of RBCs (not significant). The data in Fig. 1 show that chronic alcoholic patients had significantly decreased cAMP levels both before (P < 0.01) and after (P = 0.03) surgery compared with non-alcoholic patients. There were no significant differences in pre-and post-operative serotonin and cGMP levels between the two groups (Figs 2 and 3 ). Within the chronic alcoholic and non-alcoholic groups, there were no significant changes in Long-term alcoholics had a significantly lower (P = 0.04) platelet count than nonalcoholics before surgery (Table 3) . No significant differences were detected between chronic alcoholics and non-alcoholics in regard to platelet aggregation induced by ADP, epinephrine, collagen or ristocetin before and after surgery ( Table 4 ). Within the groups of chronic alcoholics and non-alcoholics, significantly increased postoperative epinephrine-induced aggregation was found (P < 0.01 and P = 0.02, The major finding of this study is that long-term alcoholic patients had significantly reduced levels of cAMP in PRP both pre-operatively and post-operatively (P < 0.01 and P = 0.03, respectively) compared with non-alcoholic patients. Previous studies have demonstrated decreased plasma cAMP levels in chronic alcoholics. 10 In contrast, in vitro studies on the acute treatment of vascular smooth muscle cells with ethanol did not influence cAMP production significantly. 22 Gordon et al. 23 showed that there was a fast onset of increased adenosine receptor-stimulated cAMP levels when ethanol was added acutely in a clonal neural cell line. After chronic ethanol exposure, these cells require ethanol to reach normal levels of adenosine receptor-stimulated cAMP, which may indicate a form of cellular dependence. 23, 24 Lymphocytes from chronic alcoholic patients exhibited reduced basal and reduced stimulated cAMP levels and increased resistance to ethanol stimulation of adenosine receptor-dependent cAMP accumulation. 23, 25 Recent studies have focused on adenylyl cyclase, which is activated via receptor-modulated G-protein and generates cAMP. Alcoholic patients exhibited significantly reduced values of adenylyl cyclase compared with controls, 26 and one study showed that alcoholic patients older than 55 years had decreased adenylyl cyclase activity. 27 These findings could offer an explanation of the results of the present study, particularly as the mean age of the patients was 59 years. Ratsma et al. 28 suggested that the observed reduction in cAMP formation by platelet membranes of alcoholics could be due to a persistent cellular effect of previous alcohol exposure. Their results are not fully comparable with the present findings because the cAMP concentrations were measured in PRP rather than in platelets only. Significantly lower (P = 0.04) platelet counts before surgery were detected in alcoholics than in non-alcoholics in our study. Previous studies have also shown reduced platelet counts in chronic alcohol misusers due to alcohol-induced suppression of thrombopoiesis at the level of megakaryocyte maturation. 29, 30 Since decreased cAMP levels were found both before and after surgery, the platelet count seems to have no major influence on cAMP levels in PRP.
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In humans, almost all circulating serotonin is transported by platelets in dense granules. Serotonin is a naturally weak platelet agonist. Serotonin concentrations sufficiently high for platelet activation are available only after release from dense granules in response to activation. 31 The present results show no differences in serotonin levels either between or within the groups of chronic alcoholic and nonalcoholic patients. In patients with acute alcohol ingestion no significant changes in plasma serotonin concentrations were found. 32 In contrast, it was demonstrated that alcoholics had reduced serotonin levels in both platelets (367.0 ± 474.9 versus 518.0 ± 317.6 ng/10 9 platelets) 33 and plasma compared with controls. 16 Schmidt et al. 33 showed that, after short-term abstinence, serotonin values had increased in alcoholics and were no longer significantly different from those of controls. Normally, plasma levels of serotonin are very low, typically 0.1 -10 ng/ml, compared with values related to platelets of between 161 ng/10 9 platelets measured by ELISA 17 and 884 ± 202 ng/10 9 platelets measured by high-pressure liquid chromatography with electrochemical detection. 34 The results of our study confirm these findings. In contrast to Naesh et al., 35, 36 we did not see reduced active re-uptake of serotonin into platelets after major abdominal surgery. This finding supports an earlier report of a post-stress increase in plasma serotonin. 36 Our study on serotonin concentration revealed no significant changes before versus after surgery, however. The hypothesis that the reduction in serotonin levels in chronic alcoholics may therefore be an explanation for the increased frequency of bleeding disorders is not supported by the results of the present study.
We studied ex vivo the effects of long-term alcohol misuse on the peri-operative accumulation of cGMP in PRP. No significant differences between cGMP levels before and after surgery were seen, either within or between the groups. Chen and Chai 37 demonstrated that plasma cGMP increased significantly during open-heart operations with cardiopulmonary bypass and returned to normal at the end of surgery. An in vitro trial found an inhibitory effect on cGMP accumulation in platelets that were incubated in alcohol and stimulated by the nitric oxide donor sodium nitroprusside. 11 Sodium nitroprusside induced a dosedependent increase in platelet cGMP, which was inhibited by concentrations of ethanol as low as 17 mmol/l (78 mg/dl), a level that can be achieved by moderate drinking. Relatively low concentrations of alcohol were capable of blocking cGMP accumulation in platelets. The authors stated that the mechanism of the inhibition of cGMP accumulation apparently did not involve stimulation of platelet phosphodiesterase, because alcohol inhibited platelet cGMP production in either the presence or absence of the cGMP-phosphodiesterase inhibitor zaprinast. Another indication that alcohol did not stimulate phosphodiesterase was the finding that basal platelet cGMP was not significantly reduced by alcohol treatment.
Alcohol appears to either inhibit guanylyl cyclase (under its action the intracellular cGMP is derived from guanosine triphosphate) or enhance the degradation of or block the action of nitric oxide. 11 A recent study found that cGMP-induced platelet responses are biphasic: there is first an early stimulatory response that promotes platelet activation, and this is followed by delayed platelet inhibition that serves to limit the size of platelet aggregates. This may explain the rare controversial results. 38 In order to evaluate peri-operative platelet function in vitro, we measured aggregation responses to several inducing agents. We did not find significant differences in the platelet aggregation responses that were induced. This is in contrast to previous results in which an inhibitory effect of alcohol on platelet aggregation responses was described. 4 -6 In vivo, platelet aggregation occurs under the influence of various combinations of agonists that can act synergistically through different receptors and signalling pathways (collagen, thrombin, ADP, thromboxane A2, plateletactivating factor, serotonin, epinephrine). 5 Furthermore, high intracellular levels of cAMP block the formation of small and large aggregates, leading to the inhibition of the platelet aggregation response. 9 Perioperatively diminished cAMP levels in PRP could be one explanation for decreased inhibition of platelet aggregation. Platelet aggregation is the culmination of a cascade of signalling events triggered by the initial binding of an agonist, and the inhibitory effect of ethanol on aggregation could be exerted at any number of sites along the numerous signalling pathways initiated in activated platelets. Since binding of an agonist to a receptor on platelets is the first of many events leading to aggregation, this step offers an obvious point at which ethanol may exert its inhibitory action. 39 In conclusion, to the authors' knowledge this study is the first to have examined cAMP, cGMP and serotonin levels in PRP, and platelet aggregation responses in long-term alcoholic patients undergoing major surgery. These patients exhibited a decreased cAMP level in PRP before and after surgery. The findings suggest that cGMP and serotonin do not influence peri-operative haemostasis. In contrast to previous studies, it was not possible to demonstrate significantly altered platelet aggregation responses in long-term alcoholic patients compared with nonalcoholic patients. A possible explanation could be decreased inhibition through diminished cAMP levels. Nevertheless, the underlying pathway has not been clarified and further investigations are needed to define the mechanisms of bleeding complications in patients with chronic alcohol misuse.
